CNS Drugs

, Volume 20, Issue 2, pp 153–166

Biological Markers of Age-Related Memory Deficits

Treatment of Senescent Physiology
Review Article


In humans, age-related memory impairments begin in mid-life and cognitive weakening continues with advancing age. An important aspect of defining memory decline is the distinction between dementia as a result of neurological diseases, such as Alzheimer’s disease, and memory loss not specifically associated with disease. Within the population of elderly without dementia, there is considerable variability in memory. This variability is likely to be a result of the interaction of genetic make-up and environment, which influences several processes for cell maintenance and repair including oxidative damage and cholesterol metabolism, leading to disruption of Ca2+ homeostasis, and ultimately Ca2+-dependent processes that underlie memory. In humans, several methods have been employed to distinguish biological markers of aging that may predict cognitive decline.

Memory deficits associated with normal aging and Alzheimer’s disease have been linked to a decrease in the volume of brain structures, such as the hippocampus and to genetic markers, such as apolipoprotein E. In this regard, examination of CSF for biomarkers of disease can help in differentiating normal aging from Alzheimer’s disease. Measures of oxidative stress and cholesterol in plasma correlate with memory deficits; research suggests that treatments that reduce oxidative stress or cholesterol through exercise, diet or the use of antioxidant vitamins may delay cognitive decline.

Nevertheless, to date, very little treatment is available to reverse memory deficits in later life. In this regard it is important to identify individuals at risk for memory deficits in order to discriminate different mechanisms of brain aging and develop treatments.

Considerable effort is driving research to develop accurate biological markers of brain aging. In turn, these markers will provide information on mechanisms of aging and cognitive decline and point to potential treatments. Accordingly, the effectiveness of treatment needs to be verified for both cognitive changes and biological markers that are specific for age-related memory deficits.


  1. 1.
    Larrabee GJ, Crook III TH. Estimated prevalence of age-associated memory impairment derived from standardized tests of memory function. Int Psychogeriatr 1994; 6(1): 95–104PubMedCrossRefGoogle Scholar
  2. 2.
    Kral VA, Senescent forgetfulness: benign and malignant. CMAJ 1962. 86: 257–60Google Scholar
  3. 3.
    Crook T, Bartus RT, Ferris SH, et al. Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Dev Neuropsychol 1986; 2: 261–76CrossRefGoogle Scholar
  4. 4.
    Verhaeghen P, Salthouse TA. Meta-analyses of age-cognition relations in adulthood: estimates of linear and nonlinear age effects and structural models. Psychol Bull 1997; 122(3): 231–49PubMedCrossRefGoogle Scholar
  5. 5.
    Park DC, Lautenschlager G, Hedden T, et al. Models of visuospatial and verbal memory across the adult life span. Psychol Aging 2002; 17(2): 299–320PubMedCrossRefGoogle Scholar
  6. 6.
    Zelinski EM, Gilewski MJ, Schaie KW. Individual differences in cross-sectional and 3-year longitudinal memory performance across the adult life span. Psychol Aging 1993; 8(2): 176–86PubMedCrossRefGoogle Scholar
  7. 7.
    Small SA, Stern Y, Tang M, et al. Selective decline in memory function among healthy elderly. Neurology 1999; 52(7): 1392–6PubMedCrossRefGoogle Scholar
  8. 8.
    Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 1994; 6(1): 63–8Google Scholar
  9. 9.
    Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56(3): 303–8PubMedCrossRefGoogle Scholar
  10. 10.
    Jack Jr CR, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55(4): 484–9PubMedCrossRefGoogle Scholar
  11. 11.
    Rusinek H, De Santi S, Frid D, et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 2003; 229(3): 691–6PubMedCrossRefGoogle Scholar
  12. 12.
    Khachaturian ZS. Hypothesis on the regulation of cytosol calcium concentration and the aging brain. Neurobiol Aging 1987; 8(4): 345–6PubMedCrossRefGoogle Scholar
  13. 13.
    Khachaturian ZS. Calcium hypothesis of Alzheimer’s disease and brain aging. Ann N Y Acad Sci 1994; 747: 1–11PubMedCrossRefGoogle Scholar
  14. 14.
    Foster TC, Kumar A. Calcium dysregulation in the aging brain. Neuroscientist 2002; 8(4): 297–301PubMedCrossRefGoogle Scholar
  15. 15.
    Gallagher M, Landfield PW, McEwen B, et al. Hippocampal neurodegeneration in aging. Science 1996; 274(5287): 484–5PubMedCrossRefGoogle Scholar
  16. 16.
    Foster TC. Regulation of synaptic plasticity in memory and memory decline with aging. Prog Brain Res 2002; 138: 283–303PubMedCrossRefGoogle Scholar
  17. 17.
    Erraji-Benchekroun L, Underwood MD, Arango V, et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol Psychiatry 2005; 57(5): 549–58PubMedCrossRefGoogle Scholar
  18. 18.
    Lu T, Pan Y, Kao SY, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429(6994): 883–91PubMedCrossRefGoogle Scholar
  19. 19.
    Foster TC. Involvement of hippocampal synaptic plasticity in age-related memory decline. Brain Res Brain Res Rev 1999; 30(3): 236–49PubMedCrossRefGoogle Scholar
  20. 20.
    Toescu EC, Verkhratsky A. Ca2+ and mitochondria as substrates for deficits in synaptic plasticity in normal brain ageing. J Cell Mol Med 2004; 8(2): 181–90PubMedCrossRefGoogle Scholar
  21. 21.
    Clayton DA, Grosshans DR, Browning MD. Aging and surface expression of hippocampal NMDA receptors. J Biol Chem 2002; 277(17): 14367–9PubMedCrossRefGoogle Scholar
  22. 22.
    Sonntag WE, Lynch C, Thornton P, et al. The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing. J Anat 2000; 197 Pt 4: 575–85CrossRefGoogle Scholar
  23. 23.
    Mesches MH, Gemma C, Veng LM, et al. Sulindac improves memory and increases NMDA receptor subunits in aged Fischer 344 rats. Neurobiol Aging 2004; 25(3): 315–24PubMedCrossRefGoogle Scholar
  24. 24.
    Norris CM, Ilalpain S, Foster TC. Alterations in the balance of protein kinase/phosphase activities in parallel reduced synaptic strength during aging. J Neurophysiol 1998; 80(3): 1567–70PubMedGoogle Scholar
  25. 25.
    Starkov AA, Chinopoulos C, Fiskum G. Mitochondrial calcium and oxidative stress as mediators of ischemic brain injury. Cell Calcium 2004; 36(3–4): 257–64PubMedCrossRefGoogle Scholar
  26. 26.
    Lockhart BP, Lestage PJ. Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Exp Gerontol 2003; 38(1-2): 119–28PubMedCrossRefGoogle Scholar
  27. 27.
    Lopez A, Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev 2001; (1): CD000147Google Scholar
  28. 28.
    Koch HJ, Szecsey A, Haen E. NMDA-antagonism (memantine): an alternative pharmacological therapeutic principle in Alzheimer’s and vascular dementia. Curr Pharm Des 2004; 10(3): 253–9PubMedCrossRefGoogle Scholar
  29. 29.
    Saar D, Barkai E. Long-term modifications in intrinsic neuronal properties and rule learning in rats. Eur J Neurosci 2003; 17(12): 2727–34PubMedCrossRefGoogle Scholar
  30. 30.
    Zeng H, Chattarji S, Barbarosie M, et al. Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 2001; 107(5): 617–29PubMedCrossRefGoogle Scholar
  31. 31.
    Winblad B, Engedal K, Soininen H, et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001; 57(3): 489–95PubMedCrossRefGoogle Scholar
  32. 32.
    Grantham C, Geerts H. The rationale behind cholinergic drug treatment for dementia related to cerebrovascular disease. J Neurol Sci 2002; 203-204: 131–6CrossRefGoogle Scholar
  33. 33.
    Hedden T, Gabrieli JD. Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 2004; 5(2): 87–96PubMedCrossRefGoogle Scholar
  34. 34.
    Convit A, Wolf OT, Tarshish C, et al. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc Natl Acad Sci U S A 2003; 100(4): 2019–22PubMedCrossRefGoogle Scholar
  35. 35.
    Raz N, Gunning-Dixon FM, Head D, et al. Neuroanatomical correlates of cognitive aging: evidence from structural magnetic resonance imaging. Neuropsychology 1998; 12(1): 95–114PubMedCrossRefGoogle Scholar
  36. 36.
    Lye TC, Piguet O, Grayson DA, et al. Hippocampal size and memory function in the ninth and tenth decades of life: the Sydney Older Persons Study. J Neurol Neurosurg Psychiatry 2004; 75(4): 548–54PubMedCrossRefGoogle Scholar
  37. 37.
    de Leon MJ, DeSanti S, Zinkowski R, et al. MRI and CSF studies in the early diagnosis of Alzheimer’s disease. J Intern Med 2004; 256(3): 205–23PubMedCrossRefGoogle Scholar
  38. 38.
    Takuma K, Yan SS, Stern DM, et al. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer’s disease. J Pharmacol Sci 2005; 97(3): 312–6PubMedCrossRefGoogle Scholar
  39. 39.
    Ankarcrona M, Winblad B. Biomarkers for apoptosis in Alzheimer’s disease. Int J Geriatr Psychiatry 2005; 20(2): 101–5PubMedCrossRefGoogle Scholar
  40. 40.
    Rosen AC, Prall MW, Gabrieli JD, et al. Differential associations between entorhinal and hippocampal volumes and memory performance in older adults. Behav Neurosci 2003; 117(6): 1150–60PubMedCrossRefGoogle Scholar
  41. 41.
    Grandman M, Jack Jr CR, Petersen RC, et al. Hippocampal volume is associated with memory but not monmemory cognitive performance in patients with mild cognitive impairment. J Mol Neurosci 2003; 20(3): 241–8CrossRefGoogle Scholar
  42. 42.
    Golomb J, Kluger A, de Leon MJ, et al. Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learn Mem 1994; 1(1): 45–54PubMedGoogle Scholar
  43. 43.
    Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science 1997; 278(5337): 412–9PubMedCrossRefGoogle Scholar
  44. 44.
    Lupien SJ, de Leon M, de Santi S, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998; 1(1): 69–73PubMedCrossRefGoogle Scholar
  45. 45.
    Eberling JL, Wu C, Haan MN, et al. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging 2003; 24(5): 725–32PubMedCrossRefGoogle Scholar
  46. 46.
    Colcombe SJ, Erickson Kl, Raz N, et al. Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol A Biol Sci Med Sci 2003; 58(2): 176–80PubMedCrossRefGoogle Scholar
  47. 47.
    Small GW. Brain-imaging surrogate markers for detection and prevention of age-related memory loss. J Mol Neurosci 2002; 19(1–2): 17–21PubMedCrossRefGoogle Scholar
  48. 48.
    Andreasen N, Blennow K. CSF biomarkers for mild cognitive impairment and early Alzheimer’s disease. Clin Neurol Neurosurg 2005; 107(3): 165–73PubMedCrossRefGoogle Scholar
  49. 49.
    Celsis P. Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer’s disease? Ann Med 2000; 32(1): 6–14PubMedCrossRefGoogle Scholar
  50. 50.
    Kapaki E, Paraskevas GP, Zalonis I, et al. CSF tau protein and beta-amyloid (1–42) in Alzheimer’s disease diagnosis: discrimination from normal ageing and other dementias in the Greek population. Eur J Neurol 2003; 10(2): 119–28PubMedCrossRefGoogle Scholar
  51. 51.
    Hamet P, Tremblay J. Genes of aging. Metabolism 2003; 52(10 Suppl. 2): 5–9PubMedCrossRefGoogle Scholar
  52. 52.
    Lee CK, Weindruch R, Proila TA. Gene-expression profile of the ageing brain in mice. Nat Genet 2000; 25(3): 294–7PubMedCrossRefGoogle Scholar
  53. 53.
    Verbitsky M, Yonan AL, Malleret G, et al. Altered hippocampal transcript profile accompanies an age-related spatial memory deficit in mice. Learn Mem 2004; 11(3): 253–60PubMedCrossRefGoogle Scholar
  54. 54.
    Blalock EM, Chen KC, Sharrow K, et al. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 2003; 23(9): 3807–19PubMedGoogle Scholar
  55. 55.
    Mayford M, Kandel ER. Genetic approaches to memory storage. Trends Genet 1999; 15(11): 463–70PubMedCrossRefGoogle Scholar
  56. 56.
    Foster TC, Sharrow KM, Masse JR, et al. Calcineurin links Ca2+ dysregulation with brain aging. J Neurosci 2001; 21(11): 4066–73PubMedGoogle Scholar
  57. 57.
    Bartres-Faz D, Junque C, Lopez A, et al. Apo E influences declarative and procedural learning in age-associated memory impairment. Neuroreport 1999; 10(14): 2923–7PubMedCrossRefGoogle Scholar
  58. 58.
    Deary IJ, Whiteman MC, Pattie A, et al. Cognitive change and the APOE epsilon 4 allele. Nature 2002; 418(6901): 932PubMedCrossRefGoogle Scholar
  59. 59.
    Small BJ, Rosnick CB, Fratiglioni L, et al. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004; 19(4): 592–600PubMedCrossRefGoogle Scholar
  60. 60.
    Seeman TE, Huang MH, Bretsky P, et al. Education and APOEe4 in longitudinal cognitive decline: MacArthur studies of successful aging. J Gerontol B Psychol Sci Soc Sci 2005; 60(2): P74–83PubMedCrossRefGoogle Scholar
  61. 61.
    Driscoll I, McDaniel MA, Guynn MJ. Apolipoprotein E and prospective memory in normally aging adults. Neuropsychology 2005; 19(1): 28–34PubMedCrossRefGoogle Scholar
  62. 62.
    Kang JH, Logroscino G, De Vivo I, et al. Apolipoprotein E, cardiovascular disease and cognitive function in aging women. Neurobiol Aging 2005; 26(4): 475–84PubMedCrossRefGoogle Scholar
  63. 63.
    Helbecque N, Amouyel P. Commonalities between genetics of cardiovascular disease and neurodegenerative disorders. Curr Opin Lipidol 2004; 15(2): 121–7PubMedCrossRefGoogle Scholar
  64. 64.
    Cohen RM, Small C, Lalonde F, et al. Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women. Neurology 2001; 57(12): 2223–8PubMedCrossRefGoogle Scholar
  65. 65.
    Herz J, Bock HH. Lipoprotein receptors in the nervous system. Annu Rev Biochem 2002; 71: 405–34PubMedCrossRefGoogle Scholar
  66. 66.
    Lahiri DK. Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene. J Mol Neurosci 2004; 23(3): 225–34PubMedCrossRefGoogle Scholar
  67. 67.
    Petanceska SS, DeRosa S, Sharma A, et al. Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol. J Mol Neurosci 2003; 20(3): 395–406PubMedCrossRefGoogle Scholar
  68. 68.
    Ravaglia G, Forti P, Maioli F, et al. Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutr Health Aging 2000; 4(4): 218–22PubMedGoogle Scholar
  69. 69.
    Cutler RG, Kelly J, Storie K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer’s disease. Proc Natl Acad Sci U S A 2004; 101(7): 2070–5PubMedCrossRefGoogle Scholar
  70. 70.
    Teunissen CE, De Vente J, von Bergmann K, et al. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. Neurobiol Aging 2003; 24(1): 147–55PubMedCrossRefGoogle Scholar
  71. 71.
    Evans RM, Hui S, Perkins A, et al. Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology 2004; 62(10): 1869–71PubMedCrossRefGoogle Scholar
  72. 72.
    Quan G, Xie C, Dietschy JM, et al. Ontogenesis and regulation of cholesterol metabolism in the central nervous system of the mouse. Brain Res Dev Brain Res 2003; 146(1–2): 87–98PubMedCrossRefGoogle Scholar
  73. 73.
    Sparks DL, Scheff SW, Hunsaker III JC, et al. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 1994; 126(1): 88–94PubMedCrossRefGoogle Scholar
  74. 74.
    Refolo LM, Malester B, LaFrancois J, et al. Hypercholesterolemia accelerates the Alzheimer’s amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000; 7(4): 321–31PubMedCrossRefGoogle Scholar
  75. 75.
    Jick H, Zornberg GL, Jick SS, et al. Statins and the risk of dementia. Lancet 2000; 356(9242): 1627–31PubMedCrossRefGoogle Scholar
  76. 76.
    Rockwood K, Kirkland S, Hogan DB, et al. Use of lipidlowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002; 59(2): 223–7PubMedCrossRefGoogle Scholar
  77. 77.
    Yaffe K, Barrett-Connor E, Lin F, et al. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002; 59(3): 378–84PubMedCrossRefGoogle Scholar
  78. 78.
    Wolozin B, Kellman W, Ruosseau P, et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57(10): 1439–43PubMedCrossRefGoogle Scholar
  79. 79.
    Fassbender K, Simons M, Bergmann C, et al. Simvastatin strongly reduces levels of Alzheimer’s disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A 2001; 98(10): 5856–61PubMedCrossRefGoogle Scholar
  80. 80.
    Yehuda S, Rabinovitz S, Carasso RL, et al. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002; 23(5): 843–53PubMedCrossRefGoogle Scholar
  81. 81.
    Young G, Conquer J. Omega-3 fatty acids and neuropsychiatrie disorders. Reprod Nutr Dev 2005; 45(1): 1–28PubMedCrossRefGoogle Scholar
  82. 82.
    Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline. J Neural Transm 2003; 110(1): 95–110PubMedGoogle Scholar
  83. 83.
    Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60(7): 940–6PubMedCrossRefGoogle Scholar
  84. 84.
    Kawahara M, Kuroda Y. Intracellular calcium changes in neuronal cells induced by Alzheimer’s beta-amyloid protein are blocked by estradiol and cholesterol. Cell Mol Neurobiol 2001; 21(1): 1–13PubMedCrossRefGoogle Scholar
  85. 85.
    Goritz C, Mauch DH, Nagler K, et al. Role of glia-derived cholesterol in synaptogenesis: new revelations in the synapseglia affair. J Physiol (Paris) 2002; 96(3-4): 257–63CrossRefGoogle Scholar
  86. 86.
    Koudinov AR, Koudinova NV. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J 2001; 15(10): 1858–60PubMedGoogle Scholar
  87. 87.
    Starr JM, McGurn B, Whiteman M, et al. Life long changes in cognitive ability are associated with prescribed medications in old age. Int J Geriatr Psychiatry 2004; 19(4): 327–32PubMedCrossRefGoogle Scholar
  88. 88.
    Etminan M, Gill S, Samii A. The role of lipid-lowering drugs in cognitive function: a meta-analysis of observational studies. Pharmacotherapy 2003; 23(6): 726–30PubMedCrossRefGoogle Scholar
  89. 89.
    Wagstaff LR, Mitton MW, Arvik BM, et al. Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 2003; 23(7): 871–80PubMedCrossRefGoogle Scholar
  90. 90.
    King DS, Wilburn AJ, Wofford MR, et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 2003; 23(12): 1663–7PubMedCrossRefGoogle Scholar
  91. 91.
    Berr C, Balansard B, Arnaud J, et al. Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Arteriel. J Am Geriatr Soc 2000; 48(10): 1285–91Google Scholar
  92. 92.
    Perkins AJ, Hendrie HC, Callahan CM, et al. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999; 150(1): 37–44PubMedCrossRefGoogle Scholar
  93. 93.
    Perrig WJ, Perrig P, Stahelin HB. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 1997; 45(6): 718–24PubMedGoogle Scholar
  94. 94.
    Rinaldi P, Polidori MC, Metastasio A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging 2003; 24(7): 915–9PubMedCrossRefGoogle Scholar
  95. 95.
    Berlin D, Chong G, Chertkow H, et al. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI. Neurobiol Aging 2004; 25(4): 465–74PubMedCrossRefGoogle Scholar
  96. 96.
    Mattson MP, Pedersen WA, Duan W, et al. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer’s and Parkinson’s diseases. Ann N Y Acad Sci 1999; 893: 154–75PubMedCrossRefGoogle Scholar
  97. 97.
    Akaishi T, Nakazawa K, Sato K, et al. Hydrogen peroxide modulates whole cell Ca2+ currents through L-type channels in cultured rat dentate granule cells. Neurosci Lett 2004; 356(1): 25–8PubMedCrossRefGoogle Scholar
  98. 98.
    Bindokas VP, Jordan J, Lee CC, et al. Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine. J Neurosci 1996; 16(4): 1324–36PubMedGoogle Scholar
  99. 99.
    Sengpiel B, Preis E, Krieglstein J, et al. NMDA-induced superoxide production and neurotoxicity in cultured rat hippocampal neurons: role of mitochondria. Eur J Neurosci 1998; 10(5): 1903–10PubMedCrossRefGoogle Scholar
  100. 100.
    Hongpaisan J, Winters CA, Andrews SB. Calcium-dependent mitochondrial Superoxide modulates nuclear CREB phosphorylation in hippocampal neurons. Mol Cell Neurosci 2003; 24(4): 1103–15PubMedCrossRefGoogle Scholar
  101. 101.
    De Cabo R, Cabello R, Rios M, et al. Calorie restriction attenuates age-related alterations in the plasma membrane antioxidant system in rat liver. Exp Gerontol 2004; 39(3): 297–304PubMedCrossRefGoogle Scholar
  102. 102.
    Wu A, Ying Z, Gomez-Pinilla F. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci 2004; 19(7): 1699–707PubMedCrossRefGoogle Scholar
  103. 103.
    Beltowski J, Wojcicka G, Gorny D, et al. The effect of dietaryinduced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol 2000; 51(4 Pt 2): 883–96PubMedGoogle Scholar
  104. 104.
    Liu R, Liu IY, Bi X, et al. Reversal of age-related learning deficits and brain oxidative stress in mice with Superoxide dismutase/catalase mimetics. Proc Natl Acad Sci U S A 2003; 100(14): 8526–31PubMedCrossRefGoogle Scholar
  105. 105.
    Grodstein F, Chen J, Willett WC. High-dose antioxidant supplements and cognitive function in community-dwelling elderly women. Am J Clin Nutr 2003; 77(4): 975–84PubMedGoogle Scholar
  106. 106.
    Morris MC, Evans DA, Bienias JL, et al. Vitamin E and cognitive decline in older persons. Arch Neurol 2002; 59(7): 1125–32PubMedCrossRefGoogle Scholar
  107. 107.
    Paleologos M, Cumming RG, Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am J Epidemiol 1998; 148(1): 45–50PubMedCrossRefGoogle Scholar
  108. 108.
    Zandi PP, Anthony JC, Khachaturian AS, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 2004; 61(1): 82–8PubMedCrossRefGoogle Scholar
  109. 109.
    Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002; 287(24): 3230–7PubMedCrossRefGoogle Scholar
  110. 110.
    Milgram NW, Head E, Muggenburg B, et al. Landmark discrimination learning in the dog: effects of age, an antioxidant fortified food, and cognitive strategy. Neurosci Biobehav Rev 2002; 26(6): 679–95PubMedCrossRefGoogle Scholar
  111. 111.
    Bickford PC, Gould T, Briederick L, et al. Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res 2000; 866(1–2): 211–7PubMedCrossRefGoogle Scholar
  112. 112.
    Socci DJ, Crandall BM, Arendash GW. Chronic antioxidant treatment improves the cognitive performance of aged rats. Brain Res 1995; 693(1–2): 88–94PubMedCrossRefGoogle Scholar
  113. 113.
    Stoll S, Hartmann H, Cohen SA, et al. The potent free radical scavenger alpha-lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacol Biochem Behav 1993; 46(4): 799–805PubMedCrossRefGoogle Scholar
  114. 114.
    Cotman CW, Head E, Muggenburg BA, et al. Brain aging in the canine: a diet enriched in antioxidants reduces cognitive dysfunction. Neurobiol Aging 2002; 23(5): 809–18PubMedCrossRefGoogle Scholar
  115. 115.
    Nagai T, Yamada K, Kim HC, et al. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J 2003; 17(1): 50–2PubMedGoogle Scholar
  116. 116.
    Sack CA, Socci DJ, Crandall BM, et al. Antioxidant treatment with phenyl-alpha-tert-butyl nitrone (PBN) improves the cognitive performance and survival of aging rats. Neurosci Lett 1996; 205(3): 181–4PubMedCrossRefGoogle Scholar
  117. 117.
    Xie Z, Sastry BR. Impairment of long-term potentiation in rats fed with vitamin E-deficient diet. Brain Res 1995; 681(1–2): 193–6PubMedCrossRefGoogle Scholar
  118. 118.
    Murray CA, Lynch MA. Dietary supplementation with vitamin E reverses the age-related deficit in long term potentiation in dentate gyms. J Biol Chem 1998; 273(20): 12161–8PubMedCrossRefGoogle Scholar
  119. 119.
    McGahon BM, Martin DS, Horrobin DF, et al. Age-related changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet. Neurobiol Aging 1999; 20(6): 655–64PubMedCrossRefGoogle Scholar
  120. 120.
    Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352(23): 2379–88PubMedCrossRefGoogle Scholar
  121. 121.
    Luchsinger JA, Tang MX, Shea S, et al. Antioxidant vitamin intake and risk of Alzheimer’s disease. Arch Neurol 2003; 60(2): 203–8PubMedCrossRefGoogle Scholar
  122. 122.
    Foster TC. Interaction of rapid signal transduction cascades and gene expression in mediating estrogen effects on memory over the life span. Front Neuroendocrinol 2005; 26(2): 51–64PubMedCrossRefGoogle Scholar
  123. 123.
    Foster TC, Sharrow KM, Kumar A, et al. Interaction of age and chronic estradiol replacement on memory and markers of brain aging. Neurobiol Aging 2003; 24(6): 839–52PubMedCrossRefGoogle Scholar
  124. 124.
    Wise PM, Dubai DB, Wilson ME, et al. Estrogens: trophic and protective factors in the adult brain. Front Neuroendocrinol 2001; 22(1): 33–66PubMedCrossRefGoogle Scholar
  125. 125.
    Hibberd C, Yau JL, Seckl JR. Glucocorticoids and the ageing hippocampus. J Anat 2000; 197 Pt 4: 553–62CrossRefGoogle Scholar
  126. 126.
    Pomara N, Greenberg WM, Branford MD, et al. Therapeutic implications of HPA axis abnormalities in Alzheimer’s disease: review and update. Psychopharmacol Bull 2003; 37(2): 120–34PubMedGoogle Scholar
  127. 127.
    Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004; 39(5): 687–99PubMedCrossRefGoogle Scholar
  128. 128.
    Yaffe K, Lindquist K, Penninx BW, et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003; 61(1): 76–80PubMedCrossRefGoogle Scholar
  129. 129.
    Gasparini L, Ongini E, Wenk G. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer’s disease: old and new mechanisms of action. J Neurochem 2004; 91(3): 521–36PubMedCrossRefGoogle Scholar
  130. 130.
    Jain NK, Patil CS, Kulkarni SK, et al. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behav Brain Res 2002; 133(2): 369–76PubMedCrossRefGoogle Scholar
  131. 131.
    Manly JJ, Touradji P, Tang MX, et al. Literacy and memory decline among ethnically diverse elders. J Clin Exp Neuropsychol 2003; 25(5): 680–90PubMedCrossRefGoogle Scholar
  132. 132.
    Colcombe SJ, Kramer AF, McAuley E, et al. Neurocognitive aging and cardiovascular fitness: recent findings and future directions. J Mol Neurosci 2004; 24(1): 9–14PubMedCrossRefGoogle Scholar
  133. 133.
    Fabre C, Chamari K, Mucci P, et al. Improvement of cognitive function by mental and/or individualized aerobic training in healthy elderly subjects. Int J Sports Med 2002; 23(6): 415–21PubMedCrossRefGoogle Scholar
  134. 134.
    Hultsch DF, Hertzog C, Small BJ, et al. Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging? Psychol Aging 1999; 14(2): 245–63PubMedCrossRefGoogle Scholar
  135. 135.
    Radak Z, Kaneko T, Tahara S, et al. Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem Int 2001; 38(1): 17–23PubMedCrossRefGoogle Scholar
  136. 136.
    Molteni R, Wu A, Vaynman S, et al. Exercise reverses the harmful effects of consumption of a high-fat diet on synaptic and behavioral plasticity associated to the action of brainderived neurotrophic factor. Neuroscience 2004; 123(2): 429–40PubMedCrossRefGoogle Scholar
  137. 137.
    Devi SA, Kiran TR. Regional responses in antioxidant system to exercise training and dietary Vitamin E in aging rat brain. Neurobiol Aging 2004; 25(4): 501–8PubMedCrossRefGoogle Scholar
  138. 138.
    Vaynman S, Ying Z, Gomez-Pinilla F. Interplay between brainderived neurotrophic factor and signal transduction modulators in the regulation of the effects of exercise on synaptic-plasticity. Neuroscience 2003; 122(3): 647–57PubMedCrossRefGoogle Scholar
  139. 139.
    Schmidt-Hieber C, Jonas P, Bischofberger J. Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature 2004; 429(6988): 184–7PubMedCrossRefGoogle Scholar
  140. 140.
    Tong L, Shen H, Perreau VM, et al. Effects of exercise on geneexpression profile in the rat hippocampus. Neurobiol Dis 2001; 8(6): 1046–56PubMedCrossRefGoogle Scholar
  141. 141.
    Farmer J, Zhao X, van Praag H, et al. Effects of voluntary exercise on synaptic plasticity and gene expression in the dentate gyrus of adult male Sprague-Dawley rats in vivo. Neuroscience 2004; 124(1): 71–9PubMedCrossRefGoogle Scholar
  142. 142.
    Churchill JD, Galvez R, Colcombe S, et al. Exercise, experience and the aging brain. Neurobiol Aging 2002; 23(5): 941–55PubMedCrossRefGoogle Scholar
  143. 143.
    Swaab DF, Dubelaar EJ, Hofman MA, et al. Brain aging and Alzheimer’s disease; use it or lose it. Prog Brain Res 2002; 138: 343–73PubMedCrossRefGoogle Scholar
  144. 144.
    Le Carret N, Lafont S, Mayo W, et al. The effect of education on cognitive performances and its implication for the constitution of the cognitive reserve. Dev Neuropsychol 2003; 23(3): 317–37PubMedCrossRefGoogle Scholar
  145. 145.
    Whalley LJ, Deary IJ, Appleton CL, et al. Cognitive reserve and the neurobiology of cognitive aging. Ageing Res Rev 2004; 3(4): 369–82PubMedCrossRefGoogle Scholar
  146. 146.
    Bennett DA, Wilson RS, Schneider JA, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 2003; 60(12): 1909–15PubMedCrossRefGoogle Scholar
  147. 147.
    Kubanis P, Zornetzer SF, Freund G. Memory and postsynaptic cholinergic receptors in aging mice. Pharmacol Biochem Behav 1982; 17(2): 313–22PubMedCrossRefGoogle Scholar
  148. 148.
    Warren JM, Zerweck C, Anthony A. Effects of environmental enrichment on old mice. Dev Psychobiol 1982; 15(1): 13–8PubMedCrossRefGoogle Scholar
  149. 149.
    Frick KM, Stearns NA, Pan JY, et al. Effects of environmental enrichment on spatial memory and neurochemistry in middleaged mice. Learn Mem 2003; 10(3): 187–98PubMedCrossRefGoogle Scholar
  150. 150.
    Soffie M, Hahn K, Terao E, et al. Behavioural and glial changes in old rats following environmental enrichment. Behav Brain Res 1999; 101(1): 37–49PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  1. 1.Department of Neuroscience, McKnight Brain InstituteUniversity of FloridaGainesvilleUSA

Personalised recommendations